Oluwayemisi Ojewale

Name matching only

Publications

Citations

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

9 works in the graph, newest first.

Pharmacokinetics of Dolutegravir in Children With HIV With and Without Tuberculosis Coinfection Treated According to World Health Organization Dosing Guidelines
2026JAIDS Journal of Acquired Immune Deficiency SyndromesJournalOpen access0 citations10.1097/qai.0000000000003862
Pharmacokinetics of Tenofovir Diphosphate, Lamivudine Triphosphate and Emtricitabine Triphosphate in Adolescents With HIV Infection With and Without Tuberculosis Coinfection
2025The Pediatric Infectious Disease JournalJournalOpen access2 citations10.1097/inf.0000000000004831
Tenofovir diphosphate concentrations in dried blood spots predict future HIV suppression but not virologic failure in adolescents with HIV
2025AIDSJournalOpen access0 citations10.1097/qad.0000000000004245
Hepatitis B virus (HBV) viremia despite tenofovir disoproxil fumarate-containing antiretroviral therapy in persons with HBV/HIV coinfection
2024Journal of Clinical VirologyJournalOpen access7 citations10.1016/j.jcv.2024.105733
Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection
2024Antimicrobial Agents and ChemotherapyJournalOpen access4 citations10.1128/aac.00549-24
Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children
2023The International Journal of Tuberculosis and Lung DiseaseJournalOpen access5 citations10.5588/ijtld.22.0591
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression
2023AIDSJournalOpen access5 citations10.1097/qad.0000000000003764
Pharmacokinetics and pharmacodynamics of adult dolutegravir tablets in treatment-experienced children with HIV weighing at least 20 kg
2023AIDSJournalOpen access2 citations10.1097/qad.0000000000003576
Effect of HIV infection on plasma exposure to first-line TB drugs and target attainment in children
2023The International Journal of Tuberculosis and Lung DiseaseJournalOpen access2 citations10.5588/ijtld.23.0184